Merrimack Pharmaceuticals
MACK
#7786
Rank
C$0.31 B
Marketcap
$21.04
Share price
0.00%
Change (1 day)
24.44%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.15

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.15. In 2022 the company made an earnings per share (EPS) of -$0.15 an increase over its 2021 EPS that were of -$0.25.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.15-2.92%
2022-$0.15-38.89%
2021-$0.25-25%
2020-$0.33-81.54%
2019-$1.81-56.95%
2018-$4.20-108.5%
2017$49.39-390.35%
2016-$17.01-7.35%
2015-$18.3665%
2014-$11.13-39.39%
2013-$18.36-54.01%
2012-$39.92-53.71%
2011-$86.2340.37%
2010-$61.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.42-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.17 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.63 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.84 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA